TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials May 28, 1999
TCL Archive Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs. April 14, 2006
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
